Fingerprint
Dive into the research topics of 'Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically